Type 1 Diabetes
DiaKine Therapeutics' Anti-Diabetes Drug Featured in U.S. Research Report
Published in Law and Health Weekly, November 10th, 2007
Research by Dr. Jerry Nadler and Dr. Zandong Yang that could lead to a higher success rate for islet cell transplants, is among the research featured in a new report on the status of diabetes research to Congress. The research, showing that DiaKine Therapeutics' developmental drug Lisofylline (LSF) prevented the recurrence of type 1 diabetes after islet cell transplantation in mice, is part of the status report on efforts to eradicate diabetes by the National Institutes of Health (NIH).
"Our LSF research was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, which continues to provide funding for our basic research and clinical trial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Active Power, Inc.
Active Power Helps Support Metro Hospital in Achieving LEED Certification - Aggression
Researchers at University of Arizona target aggression - Aging
'Will You Still Love Me, Will You Still Need Me, When I'm 84?' - Aging
InforMedix Partners with American Pharmacies of San Antonio - Alcoholism
Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks - Alzheimer Disease
AliMed's(R) Alzheimer's Resource Guide Provides Caregivers Practical, Simple Solutions to Preserve Quality of Life - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
